Cargando…
COVID-19 and vaccination against SARS-CoV-2 in patients with neuromyelitis optica spectrum disorders
BACKGROUND: Reports on outcomes of COVID-19 in patients with neuromyelitis optica spectrum disorder (NMOSD) are scarce, as well as those related to the safety profile of the vaccines in this population. The aim of this survey is to present demographic and clinical characteristics of patients with NM...
Autores principales: | Jovicevic, Vanja, Ivanovic, Jovana, Andabaka, Marko, Tamas, Olivera, Veselinovic, Nikola, Momcilovic, Nikola, Mesaros, Sarlota, Pekmezovic, Tatjana, Drulovic, Jelena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526109/ https://www.ncbi.nlm.nih.gov/pubmed/35158424 http://dx.doi.org/10.1016/j.msard.2021.103320 |
Ejemplares similares
-
Humoral response to SARS-CoV-2 infection and vaccines against COVID-19 in patients with neuromyelitis optica spectrum disorders: Impact of immunosuppressive treatment
por: Jovicevic, Vanja, et al.
Publicado: (2022) -
Humoral response to SARS-CoV-2 COVID-19 vaccines in patients with multiple sclerosis treated with immune reconstitution therapies
por: Drulovic, Jelena, et al.
Publicado: (2021) -
In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod
por: Cavalli, Eugenio, et al.
Publicado: (2019) -
Multidisciplinary rehabilitation and steroids in the management of multiple sclerosis relapses: a randomized controlled trial
por: Nedeljkovic, Una, et al.
Publicado: (2015) -
VALIDATION OF THE BRIEF INTERNATIONAL COGNITIVE ASSESSMENT FOR MULTIPLE SCLEROSIS (BICAMS) IN A LARGE COHORT OF RELAPSING-REMITTING MS PATIENTS
por: Drulović, Jelena, et al.
Publicado: (2022)